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Plants have been utilized as herbicides, insecticides, antimicrobials, antifungals, 
antivirals, cosmetics and therapeutic agents.  Traditional medicine plays a pivotal role in health 
care around the globe. Lepidium sativum (LS) has been utilized in cooking for its peppery, tangy 
flavor and aroma and in traditional medicine. LS has been used to treat inflammation, bone 
fractures, hypertension, microbial infections, diabetes, bronchial asthma, osteoarthritis, 
constipation and other diseases. There have been no studies investigating the effects of LS seed 
extracts on preovulatory surge secretion of gonadotropin releasing hormone (GnRH), luteinizing 
hormone (LH) and follicle-stimulating hormone (FSH). The highest level of inclusion of LS 
seeds at 50% has shown lethal effects. At 10% LS seed inclusion has shown ambiguous toxic 
and non-toxic effects. There is a paucity of information on LS effects on female and male 
reproductive function. To date, LS has been shown in females to act as a galactagogue, 
abortifacient and contraceptive. There are ambiguous results of LS having anti-ovulatory 
properties. In males, LS has been shown to increase testicular and epididymal sperm 
concentration and act as an aphrodisiac. The objectives of the study were to determine the effect 
of aqueous LS seed extract on the development and magnitude of surge releases of GnRH, LH 
and FSH and secondly, to determine the acute and chronic effects of 15% LS seed 
supplementation on gross organ morphology and histomorphometric indices, testosterone 
secretion and spermatogenesis in the Sprague-Dawley rat. 
Thirty-two female Sprague-Dawley rats were ovariectomized using standard procedures 
for Experiment 1. Ten days post-ovariectomy, all rats were injected with estradiol-17β (10 μg/0.2 
mL/rat, s.c. in corn oil) for three days. On the fourth day at 0800 h, sixteen rats were treated with 
3 
 
LSE (40 mg/Kg BW, i.p.) while the remaining sixteen received normal saline diluent at the same 
rate. At 1000 h, eight rats that received LSE and eight rats that received normal saline were 
treated with corn oil (0.2 mL/rat, s.c.). The remaining sixteen rats were treated with progesterone 
(2.5 mg/0.2 mL/rat, s.c. in corn oil). At 1300 h, the rats were euthanized using an overdose of 6 
mL 2.5% tribromoethanol. The hypothalamus and pituitary glands were extracted and perifused 
in artificial cerebrospinal fluid for seven hours at a constant temperature of 37°C. Hypothalamic 
GnRH and pituitary LH and FSH concentrations were determined utilizing radioimmunoassays. 
There were no significant differences in GnRH, LH or FSH secretions. There was an observed 
GnRH surge in rats receiving saline and progesterone. Rats that received LSE and progesterone 
observed an earlier and diminished secretion of GnRH, but was not significant. Progesterone 
administration had a suppressive effect on LH average secretion. GnRH administration had no 
effect on LH or FSH secretion. Total hormonal secretions for GnRH, LH and FSH had no 
significant changes. 
Forty-eight male Sprague-Dawley rats were utilized for Experiment 2. Upon arrival, rats 
were given feed and water ad libitum for two weeks for acclimation. The rats were weighed and 
assigned to either a control group (0% LS seed inclusion; n=24) or a treatment group (15% LS 
seed inclusion; n=24). At 0800 h rats were offered either normal rat chow or the 15% LS seed 
included rat chow for 8 weeks. At 2, 4, 6 and 8 weeks, six rats from each the Control or the 
Treatment groups were euthanized with carbon dioxide asphyxiation for a minimum of 10-
minutes. All rats were weighed on the first day of the experiment, every other day and 
immediately after euthanization. Every day feed intake and refusal was measured.  Immediately 
post euthanization, trunk blood was collected for hormone assays. Further, the paired testicles, 
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epididymides, prostate gland, seminal vesicles, kidneys, adrenal glands, heart, liver, spleen, 
lungs, brain and pancreas were harvested and weighed. The relative organ weights were 
normalized to weight per 100 g BW. One kidney and one testis was collected and used for 
histological analysis. The other testes were utilized for in vitro testosterone production. One 
cauda epididymis per rat was isolated and used for epididymal sperm count. Our results indicated 
a decrease in Treatment group’s body weight during the first few days of the experiment. This 
occurred concurrent with a strong feed aversion for the Treatment group during the first few 
days. This effect is explained by the novel food source being offered to the rats. There was no 
effect of LS seed inclusion on adrenal gland, heart, liver, and spleen or lung weight. There was a 
significant increase in brain weight possibly due to hydrocephalus. There was also a significant 
increase in pancreatic weight possibly due to pancreatitis. There were no effects of LS 
supplementation on paired testicular, epididymides or seminal vesicle weights. The prostate 
gland did show a significant decrease in weight. The mechanism for this significant weight 
decrease is unknown. The testis histological analysis had no significant results except for an 
increase in week two Leydig cell diameter. There was no significant changes for in vitro 
testosterone production or plasma testosterone. Therefore, our results suggest no conclusive data 
for the aphrodisiac claims. The epididymal sperm density did not have significant changes, 
although they did increase concurrent between the groups through the experiment. Interestingly, 
there was an increase in renal weight through the experiment for the Treatment group. 
Histological analysis showed a significant change in the diameter of the Bowman’s capsule, 
glomerulus and Bowman’s space for the Treatment group. There was also an increase in 
glomerulosclerosis, metaplasia and hyperplasia in rats fed 15% LS seed inclusion. In the 
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proximal and distal tubules there was a significant increase in tubular degeneration throughout 
the experiment. These results paired together show a significant toxic effect for rats fed 15% LS 
seed. Overall, LS seed consumption for medicinal purposes should be consumed with caution 
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Chapter I: Introduction 
The first synthesized drug did not appear until 1869. The drug chloral hydrate was 
utilized as a sedative-hypnotic (Jones, 2011). Prior to 1869 medicinal drugs were plant-derived. 
The usage of plants in traditional medicine dates back nearly 60,000 years ago. At a Neanderthal 
burial site in Shanidar, Iraq eight species of medicinal plants were exhumed with Neanderthal 
bodies, seven of which are still utilized today for their medicinal properties (Solecki, 1975). 
Apart as a food source, plants have been utilized as herbicides (Dayan & Duke, 2014), 
insecticides (Zoubiri & Baaliouamer, 2014), antimicrobials (Upadhyay, Upadhyaya, Kollanoor-
Johny, & Venkitanarayanan, 2014), antifungals (Trakranrungsie, 2011), antivirals (Babar, Zaidi, 
Ashraf, & Kazi, 2013), cosmetics (Gediya, Mistry, Patel, Blessy, & Jain, 2011) and therapeutic 
agents (Veeresham, 2012). Important drugs that have been derived from plants include digoxin, 
quinine, quinidine, vincristine, vinblastine, atropine, morphine and codeine (Rates, 2001). 
Approximately 80% of pharmaceuticals are derived from natural compounds or natural products 
(Maridass & John De Britto, 2008). It is estimated that 50% of pharmaceuticals were first 
identified from plants and other organisms (Krief, Martin, Grellier, Kasenene, & Sévenet, 2004).  
It is estimated that there are 450,000 angiosperm species (Pimm & Joppa, 2015) and 
about 1000 gymnosperms species (Christenhusz, et al., 2011). Of the existing plant species only 
6% have been investigated for pharmacological properties and 15% have been investigated for 
phytochemical properties (Atanasov, et al., 2015). That means only about 27,000 plants have 
been systematically investigated for pharmacological properties and 68,000 plants for 
phytochemical properties. When utilized in traditional medicine, plants first need to be extracted 
to separate the medicinally-active chemicals utilizing selective solvents (Handa, Khanuja, 
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Longo, & Rakesh, 2008). Extraction techniques include maceration, infusion, percolation, 
decoction, Soxhlet, microwave-assisted, ultrasound-assisted, accelerated solvent and 
supercritical fluid extraction (Azwanida, 2015). Depending on the solvent used different 
compounds can be extracted. Nonpolar compounds can be extracted efficiently by hexane, 1-
chlorobutane, dichloromethane, chloroform, isopropyl ether, ethyl ether, ethyl acetate and 1-
butanol. Polar compounds need a polar solvent to efficiently extract the compounds (Siek, 1978). 
Alcohols like ethanol and methanol utilized as solvents in extractions have proven to be more 
efficient than water (aqueous extraction) in extracting phytochemicals (Gberikon, Adeoti, & 
Aondoackaa, 2015). 
Plant and animal-derived medicines are important because of the 252 essential chemicals 
distinguished by the World Health Organization, 11.1% originate from plants while 8.7% 
originate from animals (Costa-Neto, 2005). In 2007, it was reported that nearly 38% of adults 
and 12% of children used some form of traditional medicine in the USA within a twelve month 
period (Barnes, Bloom, & Nahin, 2008). In a recent survey, estimates for adults who have 
utilized homeopathic remedies was 3.9% among USA, United Kingdom, Australia, Israel, 
Canada, Switzerland, Norway, Germany, South Korea, Japan and Singapore (Relton, Cooper, 
Viksveen, Fibert, & Thomas, 2017). Interestingly, it is estimated that at least 50% of the 
populations in Europe, North American and other developed regions have used traditional 
medicine at least once. In developing countries it is estimated that up to 80% of the population 
utilizes traditional medicine as their primary health care (World Health Organization, 2003). 
Traditional medicine is advantageous because of the ease of access and low cost. In many parts 
of the world traditional medicine is also used in regular cultural traditions.  
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Lepidium sativum (LS), commonly known as garden cress, is an annual and fast growing 
herb (Panwar & Guha, 2014). LS belongs to the Brassicaceae family. It is utilized as a spice for 
its peppery, tangy flavor and aroma.  The plant grows up to 50 cm tall originating from 4 mm 
long and 2 mm wide seeds. LS has been utilized in traditional medicine to treat inflammation, 
bone fractures, hypertension, microbial infections, diabetes, bronchial asthma, osteoarthritis, 
constipation and to increase milk production (Falana, Nofal, & Nakhleh, 2014). Although there 
is a dearth of information on the efficacy, safety and mechanism of action for the utilization of 
LS in traditional medicine there is a paucity of information on LS and its role in the control of 
reproduction.  
Reproduction in all mammals is regulated by the hypothalamic-pituitary-gonadal axis. 
The hypothalamus sits atop the axis and secretes the decapeptide gonadotropin-releasing 
hormone (GnRH). In both mammalian males and females, GnRH is secreted in a pulsatile 
fashion.  This pulsatility in turn leads to pulsatile secretion of luteinizing hormone (LH) and 
follicle-stimulating hormone (FSH) which function to stimulate production of ovarian estrogen 
and progesterone and testicular testosterone. LH and FSH also play a pivotal role in modulating 
gametogenesis. In mammalian females only, there is an increased release of GnRH called the  
surge secretion of GnRH.  As with the pulsatile mode of secretion, the GnRH surge causes the 
surge secretions of LH and FSH.  The LH surge occurs immediately before and causes ovulation.  
The neuroendocrine regulation of both pulsatile and surge secretions of GnRH and the 
gonadotropins has been well-described (Plant & Zeleznik, 2015).  Generally, it is known that 
different hypothalamic areas regulate these two modes of hormonal synthesis and secretion and 
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that all influences on reproduction, both internal and external, impact reproduction via these 
hypothalamic areas.   
To date, there have been no studies investigating the effects of LS seed extracts on 
preovulatory surge secretion of GnRH, LH and FSH. Although it has been shown that 10% LS 
supplementation in Wistar rats was nontoxic (Datta, Diwakar, Viswanatha, Murthy, & Naidu, 
2011), questions have been asked about the exact physiologic or pharmacologic level of 
inclusion of LS in animal feeds.  Further, it is unclear what the consequences of this level of LS 
inclusion for reproduction and somatic development might be. The objectives of the study are to 
determine the effect of aqueous LS seed extract on the development and magnitude of surge 
releases of GnRH, LH and FSH and secondly, to determine the acute and chronic effects of 15% 
LS seed supplementation on gross organ morphology and histomorphometric indices, 













Chapter II: Literature Review 
Plant-Derived Medicine and their Contributions to the World 
 Plant-derived medicine plays a pivotal role in healthcare worldwide. Even though there 
has been a recent increase over the past few decades in molecular modeling, combinatorial 
chemistry and synthetic chemistry methods the plant derived medicinal compounds have played 
a crucial source in the pharmaceutical industry (Salim, Chin, & Kinghorn, 2008). In 2001, 
approximately 25% of all drugs prescribed originated from plants (Rates, 2001). On average it 
takes about ten to twelve years for a drug to travel from the discovery stage to the market. 
Interestingly, twelve years later about 45% of top selling drugs originated from natural products 
in the environment (Lahlou, 2013). Apart from plant derivatives being utilized in the 
pharmaceutical industry, they also play a pivotal role in primary health care in developing 
countries.  
Lepidium sativum: Botany, Distribution and Chemical Composition 
 Lepidium sativum (LS), commonly known as garden cress, is an annual, edible, fast 
growing herb which belongs to the Brassicaceae family (Panwar, et al., 2014). LS is cultivated in 
Africa, North America, parts of Europe (Nuez & Hernandez Bermejo, 1994) and India 
(Nadkarni, 1976). The requirements for LS are simple and broad. This means the plant can grow 
in moist soil with semi-shade or even in the absence of shade (Falana, et al. 2014). After sowing 
the seeds, they will begin to sprout four to six days later. To ensure a continuous supply of LS 
leaves farmers will sow the seeds in intervals of eight days (Wadhwa, Panwar, Agrawal, Saini, & 
Patidar, 2012). LS is used as a culinary ingredient for its peppery, tangy flavor and aroma. The 
seeds are small with a length ranging from 3-4 mm long and a width of 1-2 mm. They are 
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smooth, oval-shaped, pointed and triangular at one end with a reddish brown color (Doke & 
Guha, 2014).  
LS seeds contain 22.7% of oil from a hexane extraction. The oil constituents revealed 
oleic (30.6%), linolenic (29.3%), gondoic (11.1%), palmitic (9.4%) and linoleic acids (7.6%). 
There was a large amount of the antioxidants γ- (1422 ppm), δ-(356 ppm) and α-tocopherols (21 
ppm). The primary phytosterols include sitosterol (5.82 mg/g), campesterol (3.95 mg/g) and 
avenasterol (3.44 mg/g). Other phytosterols include cholesterol (0.50 mg/g), stigmaterol (0.30 
mg/g), dihydrolanosterol (0.25 mg/g) and β-amyrin (0.16 mg/g) (Moser, Shah, Winkler-Moser, 
Vaughn, & Evangelista, 2009). Presence of carbohydrate and major sugars include mannose 
(38.9%), arabinose (19.4%), galacturonic acid (8%), fructose (6.8%), glucuronic acid (6.7%), 
galactose (4.7%), rhamnose (1.9%) and glucose (1.0%) (Karazhiyan, et al., 2009). LS seeds have 
been shown to include the isoflavonoids 7-hydroxy-4’,5,6-trimethoxyisoflavone, 7-hydroxy-5,6-
dimethoxy-2’,3’-methylenedioxyisoflavone and 5,6-dimethoxy-2’,3’-methylenedioxy-7-C-β-D-
gluco-pyranosyl isoflavone (Sakran, Selim, & Zidan, 2014). Gallic acid is utilized as a standard 
for determining total phenolic content. This yields a gallic acid equivalent (GAE). Total 
polyphenolic content for whole LS seeds are 2,081 mg GAE/100 g (Doke & Guha, 2015). 
Ethanolic extract had evidence of cardiac glycosides, anthroquinone glycoside, cyanogenetic 
glycoside, flavonoids, alkaloids, tannins, glycine, cysteine and glutamine (Yadav, Jain, 
Srivastava, & Jain, 2011). The seeds contain benzylglucosinolate ~170 μmol/g dry weight. Eight 
day old seedlings also contained isothiocyanate, thiocyanate and nitrile hydrolysis products 
(Burow & Bergner, 2007). The β-carotene content was 433.41 μg/100 g. Zeaxanthin content was 
2.35 μg/100 g. Lutein content was 96.21 μg/100 g. The total carotenoids content was 1.00 
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μmol/100 g (Diwakar, 2010). Lepidine, an alkaloid, was found in the seeds at a content of 3.7 
mg/g dry weight. Lepidine was highest in content within the plantlets during the vegetative stage 
at 10.4 mg/g (Pande, Malik, Bora, & Srivastava, 2002). Whole LS seeds yield a multitude of 
nutrients: moisture (4.14 %), protein (22.47 %), fat (27.48 %), carbohydrate (34.24 %) and crude 
fiber (7.01 %). The minerals in LS seeds include potassium (1,193.95 mg/100 g), phosphorous 
(514.59 mg/100 g), magnesium (315.25 mg/100 g), calcium (296.60 mg/100 g), sulfur (293.02 
mg/100 g), sodium (24.64 mg/100 g), iron (7.62 mg/100 g), copper (5.53 mg/100 g), zinc (5.05 
mg/100 g), aluminum (2.82 mg/100 g), manganese (2.57 mg/100 g), boron (1.41 mg/100 g) and 
molybdenum (0.43 mg/100 g). The non-essential amino acid profile for LS seeds (g/100g 
protein) includes aspartic acid (9.76), glutamic acid (19.33), serine (4.96), glycine (5.51), alanine 
(4.83), tyrosine (2.69) and proline (5.84). The essential amino acid profile for LS seeds (g/100g 
protein) include histidine (2.66), threonine (4.51), arginine (8.04), valine (5.67), methionine 
(0.97), phenyl alanine (5.65), isoleucine (5.11), leucine (8.21) and lysine (6.26) (Gokavi, 
Malleshi, & Guo, 2004). The antioxidant properties of LS seeds had a 94.18% DPPH inhibition 
and a reducing power assay absorbance of 0.749 (Panwar, et al., 2014). 
Lepidium sativum and Medicinal Utility 
 LS has been utilized to treat various human ailments such as seminal weakness, cold, 
bronchial asthma (Paranjape & Mehta, 2006), hyperglycemia (Eddouks, Maghrani, Zeggwagh, & 
Michel, 2005), osteoarthritis (Raval & Pandya, 2009), fracture healing (Juma, 2007), cough, 
dyspepsia, diarrhea (Manohar, et al., 2009), dysentery, leukorrhea, liver disease (Sakran, et al., 
2014), renal diseases, skin, eye diseases and scurvy (Billore, Yelne, Dennis, & Chaudhari, 2005). 
It is also considered having antihypertensive effects and acts as a diuretic (Maghrani, Zeggwagh, 
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Michel, & Eddouks, 2005), thermogenic, depurative, ophthalmic, tenesmus, secondary syphilis 
and leprosy (Manohar, Viswanatha, Nagesh, Vishal, & Shivaprasad, 2012). LS has also been 
shown to have a high inhibitory effect against the pathogenic organisms Staphylococcus aureus, 
Escherichia coli, Klebsiella pneumonae and Proteus vulgaris. LS acted similar to standard 
antibiotics Gentamicin and Ketoconzol when tested for inhibitory effects on Pseudomonas 
aeruginosa and Cadida albicans (Adam, Salih, & Abdelgadir, 2011). It has been observed that 
2.25% LS seed supplementation in broilers had no adverse effects (Shawle, Urge, & Animut, 
2016) and 10% LS seed supplementation was nontoxic in Wistar rats (Datta, et al., 2011). 
Another study observed nontoxic effects at 2% LS seed supplementation, toxic effects but 
nonfatal at 10% and lethal and depressed growth rate at 50% in albino rats (Adam, 1999). 
Lepidium sativum and Reproductive Regulation 
 To date, there have only been a handful of studies performed investigating the effects of 
LS on reproduction. LS seeds have been shown to act as a galactagogue (Kumar, Baghel, & 
Khare, 2011), abortifacient (Nath, Sethi, Singh, & Jain, 1992) and contraceptive (Sharief & Gani, 
2004) in females. LS has been cited in many articles for anti-ovulatory properties but in one 
study with an ethanolic extract of LS seeds there was 0% inhibition of ovulation in rabbits 
(Vohora, Khan, & Afaq, 1973). Interestingly, LS seeds in males have been shown to increase 
testicular and epididymal sperm concentration (Naji & Abood, 2013a, 2013b) and act as an 
aphrodisiac (Mali, Mahajan, & Mehta, 2007). Therefore, contrasting results exist regarding the 





Hypothalamic Regulation of Reproduction 
 Reproduction in all mammals is regulated by the hypothalamic-pituitary-gonadal axis. 
The highest level of control happens at the hypothalamus. The hypothalamus is part of the 
diencephalon that lies below the thalamus. It forms the walls and lower part of the third ventricle 
of the brain. The rostral boundary of the hypothalamus is the optic chiasm while on the posterior 
end is the mammillary bodies. At the lower part of the third ventricle is the tuber cinereum. 
Located on the tuber cinereum is a small swelling known as the median eminence. This structure 
is part of the anatomical link between the hypothalamus and anterior pituitary gland. The interior 
region of the median eminence is responsible for housing the axonal fibers of neurons 
responsible for secreting oxytocin and vasopressin. The external region of the median eminence 
is responsible for containing the terminals of hypophysiotropic neurons. The hypophysiotropic 
neuron terminals release hypothalamic hormones into the hypophyseal portal system which will 
then travel to the anterior pituitary gland. The hypothalamus is responsible for secreting 
gonadotropin-releasing hormone (GnRH). GnRH is secreted in either a pulsatile or surge fashion. 
Pulsatile secretion is regulated by the arcuate region while surge secretion is regulated by the 
pre-optic area. Pulsatile secretion of GnRH is pivotal to maintaining the responsiveness of the 
gonadotroph. Constant infusion of GnRH has been shown to lead to a down-regulation of the 
processes responsible for gonadotropin release. The mechanism of GnRH pulsatile secretion has 
been attributed to intrinsic factors such as autocrine regulation (Karazhiyan, et al., 2009). Within 
the hypothalamic GnRH neurons are estrogen receptors alpha and beta. The expression of these 
receptors dictate that estrogen may directly modulate GnRH neuronal function. It has been 
shown that estrogen receptor beta activation led to increased GnRH secretion, cyclic adenosine 
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monophosphaste production, and action potential firing. Interestingly, when estrogen receptor 
alpha is activated subsequent activation of G protein-activated inwardly rectifying potassium 
channels. These channels then decrease because of the hyperpolarization of the cell membrane 
thus decreasing secretion of GnRH (Lüscher & Slesinger, 2010). Once GnRH has been secreted 
from the hypothalamus it travels through the hypophyseal portal system towards its target, the 
anterior pituitary gland. 
The pituitary gland is located in the sella turcica. It is separated into the posterior lobe, 
neurohypophysis, and anterior lobe, adenohypophysis. The posterior lobe is consists of neural 
tissue while the anterior lobe consists of glandular tissue. The anterior pituitary gland is 
responsible for secreting the reproductive hormones luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) in response to GnRH stimulation. LH and FSH then regulate gonadal 
functions: gametogenesis and steroidogenesis. The female gonads consist of the estrogen and 
progesterone producing ovaries while the male gonads consist of the testosterone producing 
testes. These gonadal steroids have negative feedback loops that act on the hypothalamus, long 
loop, or the pituitary gland, short loop. These negative feedback loops help maintain hormonal 
homeostasis. Ovaries and testes produce gametes: eggs and sperm, respectively. Eggs and sperm 
are created from undifferentiated gonadal cells called germ cells. 
Female Reproduction 
The ovaries consist of a tough fibrous capsule known as the tunica albuginea. The 
innermost layer is known as the medulla which is where the vessels are located. The layer 
between the medulla and tunica albuginea is the cortex. The cortex contains an abundance of 
ovarian follicles that are at various stages of development. Within each primary follicle contains 
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a primary oocyte. Surrounding the primary oocyte are granulosa cells, a basement membrane and 
an outer layer of theca cells.  
Ovaries are attached to the uterus by the ovarian ligament. There is a small gap between 
the ovary and fimbriae connected to the fallopian tube. The fallopian tube then joins with the 
uterus. At the base of the uterus connects the cervix and then the vaginal canal. The uterus 
consists of three layers: innermost endometrium, middle myometrium and outmost perimetrium. 
The female body produces gametes on a monthly cycle known as the menstrual cycle. 
The name stems from the 3-7 day bloody uterine discharge known as menses. The menstrual 
cycle is divided into two more cycles: the ovarian cycle and uterine cycle. The ovarian cycle is 
further divided into three phases: follicular phase, ovulation and luteal phase. The follicular 
phase consists of growth of follicles in the ovary which is regulated by FSH. This phase has a 
duration ranging from ten days to three weeks. During ovulation one or more follicles have 
matured leading to the release of an oocyte which is regulated by a preceding surge in LH. The 
surge in LH is produced by a surge of GnRH. One key enzyme involved with the expulsion of 
the ovum from the ovulatory follicle is cyclooxygenase 2 (COX-2). The LH surge propagates the 
synthesis of prostaglandins in the cumulus cells (Dinchuk, et al., 1995). COX-2 mediates the 
synthesis of prostaglandins from arachidonic acid (Ricciotti & FitzGeral, 2011). LH also 
modulates the luteal phase transforming the ruptured follicle into the corpus luteum. The corpus 
luteum then secretes progesterone that will prepare the uterus for pregnancy. If pregnancy does 
not occur after two weeks then the corpus luteum will regress into the corpus albicans and cease 
to secrete hormones. The ovarian cycle will then start over. 
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The uterine cycle refers to ongoing changes in the endometrial lining of the uterus 
regulated by ovarian hormones. The uterine cycle is divided into three phases: the menses phase, 
proliferative phase and secretory phase. The menses phase coincides with the beginning of the 
ovarian follicular phase. This is marked by the menstrual bleeding that occurs in the uterus. The 
proliferative phase occurs towards the end of the ovarian follicular phase. This is marked by an 
increase in the number of cells within the endometrium awaiting pregnancy. At the end of the 
proliferative phase ovulation occurs. The secretory phase coincides with the ovarian luteal phase. 
The hormones secreted from the corpus luteum convert the thick endometrial layer into a 
secretory structure. If pregnancy does not occur then the thickened endometrial layer that was 
converted to secretory structures are sloughed off during menses. 
Female Rodent Reproductive Cycle 
Female rodents are polyestrous, which includes Rattus norvegicus. The rats have an 
estrous cycle lasting four to five days. The cycle is composed of four phases: proestrus, estrus, 
metestrus and diestrus. The first phase, proestrus, is described as when the animal is coming into 
heat. The second phase, estrus, is characterized by a female animal’s readiness to receive a male 
for coitus. If conception does not take place then the female will move into the next phase, 
metestrus. This phase is characterized by the estrus effects subsiding within the reproductive 
tract. The next phase is diestrus, comparable to the luteal phase in primates. The cycle will then 
repeat back to the proestrus stage. Vaginal smears are the most common way to determine the 
phase female rats are in. Proestrus is characterized by a predominance of nucleated epithelial 
cells. The estrus phase is characterized by anucleated cornified cells. Metestrus is characterized 
by the same proportion of leukocytes, cornified and nucleated epithelial cells. Diestrus is 
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characterized by a predominance of leukocytes (Yener, et al., 2007). After diestrus, LH and FSH 
levels start to increase from the anterior pituitary gland. FSH triggers expression of LH receptors 
in the ovaries while LH will propagate the synthesis and secretion of androstenedione which 
leads to the synthesis of estrogen. During proestrus there is an increase in estrogen secretion 
which inhibits GnRH release subsequently inhibiting LH and FSH secretion. This inhibition is 
also achieved by the secretion of the ovarian hormone inhibin. Estrogen levels peak during 
midday of the proestrus phase. This peak is important because the inhibition of GnRH ceases 
thus increasing GnRH secretion and LH and FSH responsiveness to GnRH. The effects of 
estrogenic modulation here is pivotal to the surge in preovulatory GnRH, LH and FSH levels. 
There is however a second FSH surge which is GnRH-independent and occurs during ovulation 
or soon after. The second surge in FSH helps to prepare a follicle for the next cycle. During 
proestrus, progesterone levels increase and peak during ovulation. After ovulation, LH and FSH 
secretion is inhibited by progesterone and estrogen. Progesterone levels also increase with 
estrogen during proestrus which stimulates GnRH secretion which reinforces the LH 
preovulatory surge. Estrus can be induced in rats by administering estradiol-17β and 
progesterone. Once estrus begins, eight to twelve hours later ovulation occurs (Plant, et al., 
2015). 
Neural Control during Estrous Cycle 
Throughout the estrous cycle the LH secretion pattern is pulsatile. The frequency of these 
pulses are less than one pulse per hour. It has been shown that the mechanism for LH secretion is 
under a 24 h photoperiodic control. This means it can fall under the category of a circadian 
rhythm (Levine & Sawyer, 1950). Studies have shown the paired suprachiasmatic nuclei (SCN) 
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of the hypothalamus functions as a generator of the signal that is entrained to the light-dark 
rhythm. The SCN is responsible for generating 24 h rhythms. The SCN times the appropriate 
initiation of GnRH surge on the afternoon of proestrus. This surge in GnRH subsequently 
secretes a surge of LH. The estrous cycle ceases when the SCN is lesioned. As mentioned before, 
GnRH pulsatility is pivotal to maintaining responsiveness of the anterior pituitary gland. During 
the afternoon of proestrus, the GnRH pulses are interrupted by a surge in the secretion of GnRH. 
This surge will propagate the preovulatory surge in gonadotropin hormones. While the SCN 
provides daily neuronal signals for the surge secretion of GnRH, the anteroventral periventricular 
nucleus receives these signals. Combined with the ovarian hormones, a surge secretion of GnRH 
is initiated (Plant, et al., Zeleznik, 2015). 
Male Reproduction 
The testes consist of a tough fibrous capsule known as the tunica albuginea. Within the 
tunica albuginea are an abundance of seminiferous tubules. This is the location where 
spermatogenesis takes place. The interstitial tissues around the seminiferous tubules consist of 
blood vessels and testosterone producing Leydig cells. Inside the seminiferous tubules the germ 
cells or spermatogonia, mature towards the lumen into sperm cells. Sertoli cells regulate sperm 
development by secreting proteins to help nourish developing sperm cells. Spermatogonia whose 
fate is to become sperm cells mature towards the lumen of seminiferous tubules. The 
seminiferous tubule exits the testis and joins the epididymis. The epididymis is a worm like 
structure that wraps around the testis consisting of three sections: head, body and tail. The tail of 
the epididymis stores mature sperm. The tail then forms into the vas deferens. The vas deferens 
then joins into the urethra. Sperm contribute approximately 1% of the volume of semen that is 
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ejaculated. The other 99% of the semen volume come from fluid secreted by accessory glands: 
bulbourethral glands, seminal vesicles and prostate gland. The bulbourethral glands contribute a 
mucus-like fluid utilized for lubrication. The fluid also contains buffers that neutralize the 
residual acidic urine in the urethra and the acid environment of the vaginal. The seminal vesicles 
contribute prostaglandins and nutrients. The prostaglandins help influence sperm motility and 
transport in male and female reproductive tracts. The prostate gland also contributes nutrients 
with the seminal vesicles for sperm metabolism. 
Metabolism 
Metabolism begins with the intake of food. The behavioral mechanism of when to eat 
depends on hunger and satiety. These two functions are controlled by the hypothalamus by a 
tonically active feeding center and a satiety center that regulates feed intake by inhibiting the 
feed center. Peptides that have shown to increase food intake include ghrelin and orexins. 
Peptides that have shown to decrease food intake include cholecystokinin, glucagon-like peptide-
1, peptide YY, corticotropin-releasing hormone, α-melanocyte-stimulating hormone and cocaine-
and amphetamine-regulated transcript. Food begins to be broken down mechanically and 
chemically in the mouth then moves towards the stomach where the food is digested into smaller 
molecules via acid secretion. The chyme then moves into the small intestines where acinar cells 
from the pancreas further aid in digestion. The acidic chyme is then neutralized by sodium 
bicarbonate secreted by duct cells in the pancreatic duct.  Bile is then secreted from hepatocytes 
concurrent with the pancreatic enzymes and sodium bicarbonate. The bile facilitates enzymatic 
fat digestion. The broken down smaller molecules are then absorbed in the intestines. After the 
28 
 
molecules are absorbed they flow through the hepatic portal vein to the liver. The liver functions 
as a filter to remove any potentially harmful xenobiotics before they enter the rest of body. 
Apart from aiding in digestion the pancreas plays a key role in maintaining plasma 
glucose homeostasis. The pancreas secretes two key hormones: insulin and glucagon. Within the 
pancreas are structures called islets of Langerhans that contain beta cells and alpha cells. Beta 
cells are responsible for secreting insulin to lower plasma glucose levels by increasing uptake of 
glucose in the tissues. Alpha cells are responsible for secreting glucagon to increase plasma 
glucose levels by increasing the synthesis of glucose. These hormones are predominately 
responsible for plasma glucose homeostasis.  
Mammals have two bean shaped kidneys lateral to the abdominal aorta. The functions of 
the kidneys are to regulate extracellular fluid volume and blood pressure, osmolarity, 
maintenance of ion balance, excretion of wastes and production of hormones. The kidney is 
divided into an inner medullary region and an outer cortical region. Within the regions is a vast 
network of tubules called nephrons. Each nephron is initiated by a Bowman’s capsule that 
surrounds the glomerulus. The Bowman’s capsule is comprised of simple squamous epithelium. 
Blood is filtered out of the glomerulus and into the Bowman’s capsule. The filtrate then flows 
into the proximal convoluted tubule, distal convoluted tubule, and collecting duct on its way to 







Chapter III: Hypotheses 
Based on the evidence presented in the literature review section of this thesis, we 
hypothesize: 
a. females exposed to LS seed extract and P4 will have a lower amplitude GnRH surge  
b. females exposed to LS seed extract and P4 will have a lower amplitude LH surge  
c. females exposed to LS seed extract and P4 will have a lower amplitude FSH surge  
d. males fed rat chow with 15% inclusion of LS seeds will have an increased sperm 
density  
e. males fed rat chow with 15% inclusion of LS seeds will have an increased 
testosterone secretion in perifusate samples from testis parenchyma 
f. males fed rat chow with 15% inclusion of LS seeds will have an increased plasma 
testosterone level  
g. males fed rat chow with 15% inclusion of LS seeds will have histopathological 
evidence  







Chapter IV: Materials and Methods 
The research protocols utilized in this study were approved by the Institutional Animal 
Care and Usage Committee of St. Cloud State University, St. Cloud, Minnesota, USA. The 
research was conducted in accordance with the National Institute of Health’s Guide for the Care 
and Use of Laboratory Animals (2011). All experiments were carried out in the vivarium at St. 
Cloud State University, St. Cloud, Minnesota, USA. 
Plant Acquisition and Preparation 
 LS seeds were purchased from a local market in Gombe, Nigeria and confirmed in the 
Department of Forestry and Wildlife Management, Federal University of Agriculture, Abeokuta, 
Nigeria. The seeds were electrically blended to a fine powder using a single-speed food blender 
(Waring Products, Torrington, CT, USA). The LS seed powder (LSSP) was kept in an air tight 
container at 4°C until used for animal treatments. 
Aqueous Extraction of LS Seeds 
LSSP was mixed with deionized water (1 g/100 mL) for 24 h. The solution was filtered 
with a vacuum through Whatman qualitative filter paper grade 3 (GE Healthcare Bio-Sciences, 
Pittsburgh, PA, USA). The filtrate was then dehydrated in an oven for 48 h. The LS aqueous 
extract (LSE) was stored in an air tight container at 4°C. 
Experiment 1: Effect of LS Seed Extract on the Surge of GnRH, LH and FSH in 
Ovariectomized Female Rats 
Our objective of this experiment was to determine the effect of aqueous LSE on the 
development and magnitude of the surge releases in GnRH, LH, and FSH that lead to the process 





Cloud, MN, USA) weighing 200-250 g and between seven and ten weeks of age were used for 
this study. Rats were ovariectomized using standard methods and housed in individual plastic 
cages. They were maintained under a lighting regime of 12 hours under light and 12 hours in the 
dark at 25°C. Rat feed (Global Diets, Madison, WI, USA) and water were provided ad libitum. 
The rats were utilized seven to ten days after ovariectomy to allow time to heal. On days 1 to 3 at 
1000 h, all rats were injected with estradiol-17β (10 μg/0.2 mL/rat, s.c. in corn oil). On day 4 at 
0800 h, sixteen of the rats were treated with LSE (40 mg/Kg BW, i.p.) while the remaining 
sixteen received normal saline diluent at the same rate. At 1000 h, eight rats that received LSE 
and eight rats that received normal saline were treated with corn oil (0.2 mL/rat, s.c.) while the 
remaining sixteen rats, eight that received LSE and eight that received saline, were treated with 
progesterone (2.5 mg/0.2 mL/rat, s.c. in corn oil). These regimens of hormonal treatments 
produce physiological levels of plasma estradiol-17β and progesterone and consistently generate 
preovulatory-like surges of GnRH, LH and FSH. These treatments therefore produce the 
following treatment groups: Group 1: OVX+E2+Saline, n=8; Group 2: OVX+E2+LSE, n=8; 
Group 3: OVX+P4+Saline, n=8; Group 4: OVX+P4+LSE, n=8. At 1300 h, the rats were 
euthanized using an overdose of 6 mL 2.5% tribromoethanol. The hypothalamus was extracted 
by removing the brain from the skull. The brain was then inverted exposing the posterior side. 
Utilizing a scalpel and number 11blade, a cut was made immediately posterior the optic chiasm. 
Another cut was made anterior the mammillary bodies. Two more cuts were made on the ventral 
lateral ridges. The hypothalamus was then cut midsagittal to yield two hemi-hypothalamic 





and number 11 blade. The hemi-hypothalamic fragments and pituitary gland from each rat were 
then perifused. 
Perifusion of Hemi-Hypothalamic Fragments 
The hemi-hypothalamic fragments obtained from the above treatment groups were 
perifused utilizing a 12-chamber Suprafusion 1000 (Brandel, Gaithersburg, MD, USA) with 
artificial cerebrospinal fluid (aCSF) at 37°C for a period of seven hours. The perifusate fractions 
were collected at 15-minute intervals yielding a collected volume of 2 mL per fraction. GnRH 
concentrations were determined in all perifusates using radioimmunoassays. 
Perifusion of Pituitary Gland 
Pituitary glands obtained from the above treatment groups were perifused using a 6-
chamber Suprafusion 1000 (Brandel, Gaithersburg, MD, USA) with aCSF at 37°C for a period of 
seven hours. After 60 minutes, 10 ng/mL of GnRH was administered to the pituitary glands for 
30 minutes. GnRH was added to assist in surging of LH and FSH because of the severed link 
between the hypothalamus and pituitary gland. The perifusate fractions were collected at 15-
minute intervals yielding a collected volume of 2 mL per fraction. LH and FSH concentrations 
were determined in all perifusates using radioimmunoassays. 
Radioimmunoassay of GnRH 
GnRH concentrations were determined utilizing the technique by Ellinwood et al. (1985). 
GnRH (Sigma Aldrich, St. Louis, MO, USA) was iodinated using 125I (Perkin Elmer 
Laboratories, Waltham, MA, USA) by the Chloramine-T method. The GnRH standards were 1, 
5, 10, 25, 50, 100, 250, 500 and 1,000 pg/mL. The antiserum R1245 (Colorado State University, 





The radioimmunoassay (RIA) for GnRH is a three-day assay. On day 1, standards      
(200 μL), perifusate samples (200 μL) in duplicates and antibody (50 μL) were pipetted into 
12x75 mm borosilicate glass tubes (VWR International, Radnor, PA, USA). The tubes were then 
vortexed briefly and stored at 4°C for 24 h. On day 2, the tracer (125I-GnRH; 11,000 cpm/50 μL) 
was pipetted to all tubes, vortexed briefly and then stored at 4°C for 24 h. On day 3, 1.5 mL 95% 
ice cold ethanol was pipetted into all tubes as a precipitating agent and then vortexed. The tubes 
were then centrifuged at 3,000 rpm at 4°C for 20 minutes using the Sorvall RT7 plus centrifuge 
(Thermo Scientific, Waltham, MA, USA). The supernatant was discarded into a waste 
receptacle. The tubes were then loaded and counted in a Packard Cobra II gamma counter 
(Perkin Elmer, Waltham, MA, USA). 
Radioimmunoassay of LH 
LH concentrations were determined utilizing the techniques described by Bernard et al. 
(1983). LH was iodinated using 125I (Perkin Elmer Laboratories, Waltham, MA, USA) by the 
Chloramine-T method. The LH (National Institute of Diabetes and Digestive and Kidney 
Diseases, Bethesda, MD, USA) standards that were used include 0.8, 1.6, 3.1, 6.2, 12.5, 25 and 
50 ng/mL. The first antiserum AFP 240580 was utilized at 1:40,000 dilution. The second 
antibody that was used is goat anti-rabbit immunoglobulin G (GARGG, Equitech-Bio, Inc, 
Kerrville, TX, USA) at a dilution of 1:1 with 0.01 M phosphate buffered saline (PBS) and 
EDTA. 
Briefly on day 1, standards (200 μL), perifusate samples (100 μL) in duplicates, first 
antibody (100 μL) and tracer (125I-LH; 20,000 cpm/100 μL) were pipetted into 12x75 mm 





briefly before being stored at 4°C for 48 h. On day 3, the second antibody GARGG (200 μL) was 
pipetted into the tubes along with 6% polyethylene glycol (500 μL). Afterwards, the tubes were 
vortexed briefly and centrifuged at 3,000 rpm at 4°C for 15 minutes using the Sorvall RT7 plus 
centrifuge (Thermo Scientific, Waltham, MA, USA). The supernatant were discarded into a 
waste receptacle. The tubes were then loaded and counted in a Packard Cobra II gamma counter 
(Perkin Elmer, Waltham, MA, USA). 
Radioimmunoassay of FSH 
FSH concentration was determined utilizing techniques described by Odell et al. (1968). 
FSH was iodinated using 125I (Perkin Elmer Laboratories, Waltham, MA, USA) by the 
chloramine-T method. The FSH (National Institute of Diabetes and Digestive and Kidney 
Diseases, Bethesda, MD, USA) standards that were used include 0.125, 0.25, 0.5, 1.5, 2.5, 5.0, 
10.0, 20.0 and 50 ng/mL. The first antiserum AFP C528813 was utilized at 1:15,000 dilution. 
The second antibody that was used is GARGG (Equitech-Bio, Inc, Kerrville, TX, USA) at a 
dilution of 1:1 with 0.01 M PBS and EDTA.  
The RIA for FSH is a 5-day assay. On day 1, standards (200 μL), perifusate samples (200 
μL) in duplicates and first antibody (200 μL) were pipetted into 12x75 mm borosilicate glass 
tubes (VWR International, Radnor, PA, USA). The tubes were then vortexed briefly before being 
stored at 4°C for 24 h. On day 2, the tracer (125I-FSH; 20,000 cpm/100 μL) were pipetted into all 
tubes, vortexed briefly, and then stored at 4°C for 60 minutes using a Sorvall RT7 plus 
centrifuge (Thermo Scientific, Waltham, MA, USA). The supernatant was discarded into a waste 
receptacle. The tubes were then loaded and counted in a Packard Cobra II gamma counter 





Experiment 2: Effect of LS Seed Inclusion on Reproductive Hormones, Sperm 
Concentration, Metabolic and Growth Indices in Male Rats 
The objective of this experiment was to determine the acute and chronic effects of 15% 
LS seed supplementation on gross organ morphology and histomorphometric indices, 
testosterone secretion and spermatogenesis involved in metabolic and spermatogenic functions in 
the Sprague-Dawley rat.  
LS Experimental Diet 
Normal rat chow (Global Diets, Madison, WI, USA) was electrically blended using a 
single-speed food blender (Waring Products, Torrington, CT, USA) to a fine powder. The 15% 
LS experimental feed was produced by mixing 17 g of finely ground normal rat chow and 3 g of 
LSSP with 10 mL deionized water. The mixture was then pelleted by hand into six pellets. The 
pellets air-dried for 24-48 h before they were utilized as feed. 
Experimental Animals 
Forty-eight mature male Sprague-Dawley rats (Charles River Laboratories, Wilmington, 
MA, USA) weighing 250-350 g and between seven and ten weeks of age were used for this 
study. Rats were housed in individual plastic cages for two weeks prior to the experiment for 
acclimation. The rats were maintained under a lighting regime of 12 hours under light and 12 
hours in the dark at 25°C. During the acclimation period rat feed and water were provided ad 
libitum. 
After the acclimation period, each rat was weighed and assigned to either a control group 
(0% LS seed inclusion; n=24) or a treatment group (15% LS seed inclusion; n=24). The length of 





then chronic effects of feeding these seeds on metabolism and reproduction. Secondly, the 56-
day study included a period of 48 to 52 days, the duration of one spermatogenic cycle in the rat 
(Hafez, 1970). At 0800 h daily, rats were offered either normal rat chow or the 15% LS seed 
included rat chow for 8 weeks. At 2, 4, 6 and 8 weeks, six rats from each the Control or the 
Treatment groups were euthanized with carbon dioxide asphyxiation for a minimum of 10-
minutes. All rats were weighed on the first day of the experiment, every other day and 
immediately after euthanization to determine bodyweight changes. Every day feed intake and 
refusal was measured. Immediately post euthanization, trunk blood was collected for hormone 
assays. Further, the paired testes, epididymides, prostate gland, seminal vesicles, kidneys, 
adrenal glands, heart, liver, spleen, lungs, brain and pancreas were harvested and weighed. The 
relative organ weights were normalized to organ weight per 100 g BW. One kidney and one 
testis were preserved in 10% formalin buffer for histological analysis. The other testes were 
utilized for in vitro testosterone production determination. One cauda epididymis per rat was 
isolated and utilized for the epididymal sperm count.  
Kidney Histological Analysis 
The kidneys obtained for histological analysis were stored in 10% formalin until fixated 
in paraffin wax. Each kidney was sectioned at 5 μm superficially and then 100 μm deep. The 
tissue was then stained in Hematoxylin and Eosin. Pictures were taken of the Bowman’s capsule, 
glomerulus, proximal tubule and distal tubule utilizing a light microscope DM750 (Leica, 
Buffalo Grove, IL, USA) with an attached camera. The diameters of the aforementioned 





Within each structure evidence of disease presence was graded as 1, disease present, or 0, disease 
absent. The disease presence is presented as a percentage. 
Testes Histological Analysis 
The testes obtained for histological analysis were stored in 10% formalin until fixated in 
paraffin wax. Each testis was sectioned at 5 μm superficially and then 100 μm deep. The tissue 
was then stained in Hematoxylin and Eosin. Pictures were taken of the seminiferous tubules, 
germinal cell layer and Leydig cells utilizing a light microscope DM750 (Leica, Buffalo Grove, 
IL, USA) with an attached camera. The diameters of the seminiferous tubules, thickness of 
germinal cell layer and diameter of Leydig cells were measured using ImageJ (National Institute 
of Health, Bethesda, MD, USA). 
In Vitro Testosterone Production 
Two 100 mg samples (A and B) of parenchyma from each testis were loaded into 
Suprafusion 1000 equipment (Brandel, Gaithersburg, MD, USA). The parenchyma was perifused 
for three hours collecting 4 mL of perifusate at 30 minute increments at a constant temperature of 
37°C. During the first hour, all samples were perifused in 0.01 M phosphate buffered saline 
(PBS). During the second and third hours, sample A was perifused in 0.01 M PBS while sample 
B was perifused in 150 mIU/mL human chorionic gonadotropin (hCG) in 0.01 M PBS. The 
hormone hCG was utilized because of its stimulatory effect of testosterone secretion similar to 
luteinizing hormone. Perifusate fractions were stored at -80°C until assayed utilizing a double 







Epididymal Sperm Density 
The cauda epididymis was isolated by cutting approximately 1 mm down from the 
junction of the vas deferens and the cauda epididymis and also at the junction of corpus 
epididymis and cauda epididymis. The cauda epididymis weight was then obtained. The 
epididymal sperm concentrations were obtained using a Neubauer hemocytometer as described 
by Wang (2003). The sperm density was calculated as total number of sperm per cauda / cauda 
weight (mg). 
Statistical Approach 
Statistical analysis utilized the statistical software SPSS 24 (IBM, Armonk, NY, USA). 
The main effect of dose and time and their interactions on GnRH, LH and FSH secretions were 
determined using the multivariate analysis of variance (MANOVA) in experiment 1. Experiment 
2 utilized a MANOVA to analyze the effect of the treatment of the seeds and the effect of time of 
feeding for the various aforementioned measurement variables (body weights, feed intake, organ 
weights, testosterone secretions, plasma testosterone, sperm concentration and various 
histological parameters: Bowman’s capsule diameter, glomerular diameter, proximal and distal 
tubule diameter, disease presence, seminiferous tubule diameter, germinal cell layer thickness 




Chapter V: Results 
Experiment 1 
The profile of GnRH in hemi-hypothalamic fragments obtained from all treatment groups 
are shown in Figures 1-3. Ovariectomized, estrogen primed, progesterone treated rats showed 
increased GnRH secretion behavior at 180 and 240 minutes after progesterone administration. 
Although not statistically significant, this secretion corresponded to the afternoon and is 
indicative of a surge-like secretion. LSE treatment at 40 mg/Kg BW seemed to cause this surge-
like secretion to occur earlier, around 40 and 90 minutes, in the progesterone-treated rats and the 
magnitude of the surge was also attenuated. Although pulsatile, no surge-like GnRH secretion 
was observed in either saline or LSE treated ovariectomized, estrogen-primed hemi-
hypothalamic fragments. 
 Overall, average GnRH secretion was significantly greater in progesterone-treated, 
estrogen-primed rats compared to saline-treated, estrogen-primed rats (Figure 1). The total 
GnRH secretion for estrogen-primed, progesterone and saline-treated, ovariectomized rats was 
96.5 pg/mL (Table 1). The estrogen-primed, progesterone and LSE-treated, ovariectomized rats 
was slightly increased at 98.9 pg/mL, but not significant. The estrogen-primed, saline-treated, 
ovariectomized rats had similar GnRH secretions of 92.5 pg/mL. Rats that were estrogen-primed, 
LSE-treated, ovariectomized had nonsignificant decreased total GnRH secretions of 74.3 pg/mL. 
Averaged over time, perifusate LH secretion was significantly greater (p<0.05) in 
ovariectomized, estrogen-treated rats compared to ovariectomized, estrogen-primed, 
progesterone treated rats. LSE treatment had no effect on LH secretion in either the estrogen or 





 Temporally, LH secretion from the pituitary gland in all treatment groups decreased over 
time. Perifusate LH level was high varying from 15-36 ng/mL pre-GnRH administration (Figures 
4 & 5). Administration of GnRH of 10 ng/mL had no stimulatory effect on LH secretion in any 
treatment group. Consequently, no surge-like LH secretion was observed. Total LH secretions 
were similar among the ovariectomized, estrogen-primed, progesterone and saline or LSE treated 
rats, 209.4 and 208.1 ng/mL, respectively (Table 1). Ovariectomized, estrogen-primed, saline or 
LSE treated rats had similar total LH secretions of 297.4 and 301.2 ng/mL, respectively. 
 The profile of FSH in perifusates obtained from all experimental groups are shown in 
Figures 7-9. Overall, FSH decreased from time 0 to about 180 minutes and then stabilized. 
Average perifusate FSH levels were significantly higher in ovariectomized, estrogen-primed, 
progesterone-treated rats compared to ovariectomized, estrogen-primed rats. LSE administration 
significantly increased (p<0.05) average perifusate FSH secretion in the ovariectomized, 
estrogen-primed rats but had no effect in the ovariectomized, estrogen-primed, progesterone-
treated rats. Administration of GnRH at 10 ng/mL had no effect in perifusate FSH secretion. 
Total FSH secretion for ovariectomized, estrogen-primed, progesterone-treated rats were similar 
to ovariectomized, estrogen-primed, LSE-treated rats, 21.4 and 24.2 ng/mL, respectively (Table 
1). The ovariectomized, estrogen-primed rats had a nonsignificant decrease in total FSH 










Figure 1.  Perifusion of hemi-hypothalamic fragments from ovariectomized female Sprague-
Dawley rats for gonadotropin releasing hormone. Control groups receiving corn oil + saline, corn 
oil + LSE and progesterone + saline: yellow square, green triangle and purple circle, 

































Figure 2.  Perifusion of hemi-hypothalamic fragments from ovariectomized female Sprague-
Dawley rats for gonadotropin releasing hormone by period. Control groups receiving corn oil + 
saline, corn oil + LSE and progesterone + saline: yellow square, green triangle and purple circle, 


































Figure 3.  Perifusion of hemi-hypothalamic fragments from ovariectomized female Sprague-
Dawley rats for average gonadotropin releasing hormone secretion. Control groups receiving 
corn oil + saline, corn oil + LSE and progesterone + saline: yellow solid, green vertical stripes 
and purple horizontal stripes, respectively. Experimental group receiving progesterone + LSE, 


































Figure 4.  Perifusion of pituitary gland fragments from ovariectomized female Sprague-Dawley 
rats for luteinizing hormone. Control groups receiving corn oil + saline, corn oil + LSE and 
progesterone + saline: yellow square, green triangle and purple circle, respectively. Experimental 
































Figure 5.  Perifusion of pituitary gland fragments from ovariectomized female Sprague-Dawley 
rats for luteinizing hormone by period. Control groups receiving corn oil + saline, corn oil + LSE 
and progesterone + saline: yellow square, green triangle and purple circle, respectively. 































Figure 6.  Perifusion of pituitary gland fragments from ovariectomized female Sprague-Dawley 
rats for average luteinizing hormone secretion. Control groups receiving corn oil + saline, corn 
oil + LSE and progesterone + saline: yellow solid, green vertical stripes and purple horizontal 
stripes, respectively. Experimental group receiving progesterone + LSE, orange diagonal stripes. 




























Figure 7.  Perifusion of pituitary gland fragments from ovariectomized female Sprague-Dawley 
rats for follicle-stimulating hormone. Control groups receiving corn oil + saline, corn oil + LSE 
and progesterone + saline: yellow square, green triangle and purple circle, respectively. 






























Figure 8.  Perifusion of pituitary gland fragments from ovariectomized female Sprague-Dawley 
rats for follicle-stimulating hormone by period. Control groups receiving corn oil + saline, corn 
oil + LSE and progesterone + saline: yellow square, green triangle and purple circle, 






























Figure 9.  Perifusion of pituitary gland fragments from ovariectomized female Sprague-Dawley 
rats for average follicle-stimulating hormone secretion. Control groups receiving corn oil + 
saline, corn oil + LSE and progesterone + saline: yellow solid, green vertical stripes and purple 
horizontal stripes, respectively. Experimental group receiving progesterone + LSE, orange 




























Table 1. Effect of aqueous LS extract on total hormonal secretion of 
GnRH, LH and FSH from the hypothalamus and pituitary gland for 7 hours 
 
Total Hormone Secretion 
Group GnRH (pg/mL) LH (ng/mL) FSH (ng/mL) 
OVX+E₂ +Saline 92.5 ± 2.36 297.4 ± 21.85 17.0 ± 2.01 
OVX+E₂ +LSE 74.3 ± 2.10 301.2 ± 42.18 35.7 ± 2.25 
OVX+P₄ +Saline 96.5 ± 3.56 209.4 ± 20.44 21.4 ± 1.89 
OVX+P₄ +LSE 98.9 ± 3.59 208.1 ± 22.08 24.2 ± 1.90 
Values are mean ± S.E.M. of 29 female Sprague-Dawley rats. No 







Over the duration of the experiment rats fed 0% LS seed supplementation increased in 
body weight. During the first week of the experiment, rats fed 15% LS seed supplementation 
decreased in body weight (Figure 10) due to the strong feed aversion (Figure 11). During the rest 
of the experiment the treatment group gained weight at a rate concurrent with the control group. 
The control group had a slight feed aversion but remained steady during the rest of the 
experiment. Rats fed 15% LS seed inclusion had a significantly strong feed aversion during the 
first few days of the experiment. Afterwards rats in both groups ate approximately the same 
amount of feed each day (Figure 11).  
Visceral Organ Weights 
There were no significantly different paired testicular weight differences throughout the 
experiment. Although, there was a non-significant increase in paired testicular weights in rats fed 
15% LS seed inclusion during weeks four (Control: 0.840g, Treatment: 0.933 g) and six 
(Control: 0.862 g, Treatment: 0.940 g). Week two and eight paired testicular weights were 
similar (Figure 12). The epididymides weight differences were not significant (Figure 13). There 
was a significant decrease in the treatment groups prostate gland weight during weeks two 
(Control: 0.240 g, Treatment: 0.190 g) and six (Control: 0.220 g, Treatment: 0.190 g). There was 
however a nonsignificant decrease during weeks four (Control: 0.224 g, Treatment: 0.197 g) and 
eight (Control: 0.220 g, Treatment: 0.200 g) (Figure 14). There were no significant weight 
changes for the seminal vesicles weight (Figure 15). Interestingly, the control group had a 
significantly lower renal weight than the treatment group at each biological endpoint (Figure 16). 





and 0.661 g, respectively. During weeks two, four, six and eight the treatment group renal 
weights were 0.749, 0.831, 0.810 and 0.890 g, respectively. There were no significant weight 
changes for the adrenals, heart, liver, spleen and lungs (Figure 17-21). The control group brain 
weight decreased during the experiment at each biological time point. There was a nonsignificant 
weight increase for the treatment group during week two (Control: 0.480 g, Treatment: 0.497 g). 
During weeks four (Control: 0.459 g, Treatment: 0.528 g), six (Control: 0.452 g, Treatment: 
0.489 g) and eight (Control: 0.451 g, Treatment: 0.491g) the brain weight increased significantly 
(Figure 22). The pancreatic weight for the control group decreased over the duration of the 
experiment (Figure 23). Weeks two, four and six had similar pancreatic weights. The pancreatic 
weight during week eight was significantly increased in the treatment group (Control: 0.077 g, 
Treatment: 0.104 g). 
Renal Histology 
Dietary supplementation of LS seeds for eight weeks induced significant signs of toxicity 
(Tables 2 & 3). There was a trend of increasing toxicity as the experiment proceeded. The 
Bowman’s capsule diameter was not significant except in week eight (Control: 0.164 mm, 
Treatment: 0.186 mm). The diameter of the glomerulus was significantly decreased in week four 
(Control: 0.158 mm, Treatment: 0.147 mm) and significantly increased in week eight (Control: 
0.145 mm, Treatment: 0.155 mm). There was a significant increase in the difference in 
Bowman’s capsule and glomerulus in week eight (Control: 0.0194 mm, Treatment: 0.0311 mm). 
Renal histopathological analysis yielded significant increase in presence of glomerulosclerosis 
(Control Total Average: 34.6%, Treatment Total Average: 65.0%), metaplasia (Control Total 





39.8%, Treatment Total Average: 79.4%) in the treatment group’s renal corpuscle. Renal 
Bowman’s capsule and glomeruli for rats that received 0% LS seed inclusion and 15% with 
glomerulosclerosis, metaplasia and/or hyperplasia are depicted in Figure 24 for weeks two and 
four. Renal Bowman’s capsule and glomeruli for rats that receive 0% LS seed inclusion and 15% 
with glomerulosclerosis, metaplasia and/or hyperplasia are depicted in Figure 25 for weeks six 
and eight.  
The kidneys displayed abnormal proximal and distal convoluted tubule diameter and 
presence of tubule degeneration (Table 4). The proximal convoluted tubule diameter was 
significantly larger in week eight for rats receiving 15% LS seed inclusion (Control: 0.0482 mm, 
Treatment: 0.0561 mm). There was significantly increased presence of proximal convoluted 
tubule degeneration throughout the eight week experimental period. During weeks two, four, six 
and eight the proximal tubule degeneration presence was low in the control group at 0.0, 2.5, 2.5 
and 0.0%, respectively. During weeks two, four, six and eight the proximal tubule degeneration 
presence was high in the treatment group at 35.0, 60.0, 47.5 and 62.5%, respectively. The distal 
convoluted tubule diameter was significantly larger in week eight for rats receiving 15% LS seed 
inclusion (Control: 0.0396 mm, Treatment: 0.0507 mm). There was significantly increased 
presence of distal convoluted tubule degeneration throughout the eight week experimental 
period. During weeks two, four, six and eight the distal tubule degeneration presence was low in 
the control group at 10.0, 20.0, 10.0 and 15.0%, respectively. During weeks two, four, six and 
eight the distal tubule degeneration presence was remarkably high at 77.5, 70.0, 85.0 and 87.5%, 
respectively. Renal proximal tubules for rats that received 0% LS seed inclusion and 15% with 





six and eight. Renal distal tubules for rats that received 0% LS seed inclusion and 15% with 
tubular degeneration are depicted in Figure 28 for weeks two and four and Figure 29 for weeks 
six and eight. 
Testis Histology 
The testes displayed no significant change in seminiferous tubule diameter or germinal 
cell layer thickness throughout the duration of the experiment. There was a significant increase 
in Leydig cell diameter during week two (Control: 0.0123 mm, Treatment: 0.0134 mm) but 
throughout the rest of the duration of the experiment the diameters were similar (Table 5). 
 In Vitro Testosterone Synthesis 
The testosterone synthesis of the testis parenchyma was not significant throughout the 
experiment (Figure 30). Challenging testis parenchyma with hCG did not increase testosterone 
secretion. During week two there was an increase in testosterone secretion for the control group 
perifused with 0.01 M PBS 90 minutes into the perifusion at 0.2 ng/mL while the treatment 
group perifused with 0.01 M PBS, control and treatment group perifused with 0.01 M PBS + 
hCG remained at 0.1 ng/mL (Figure 30A). There was a trend of 0.1 ng/mL of testosterone 
secretion. During week four there was a decreasing trend in all groups for the first 120 minutes. 
The control group perifused with 0.01 M PBS had the lowest testosterone secretions followed by 
the control group perifused with 0.01 M PBS + hCG. Interestingly, the highest testosterone 
secretion came from the treatment group perifused with 0.01 M PBS followed by the treatment 
group perifused with 0.01 M PBS + hCG (Figure 30B). During week eight there was a 
decreasing tend in testosterone secretion for the first 90 minutes. The control group perifused 





lowest testosterone secretion was the control group perifused with 0.01 M PBS + hCG in the 
beginning. The highest testosterone secretion in the beginning of the perifusion was the treatment 
group perifused with 0.01 M PBS + hCG followed by the treatment group perifused with 0.01 M 
PBS. At 60 minutes the testosterone secretions began to have similar testosterone secretions. 
After 90 minutes each of the groups secreted approximately 0.1 ng/mL of testosterone (Figure 
30C). 
Plasma Testosterone 
The plasma testosterone level fluctuations were not significant throughout the experiment 
(Figure 31). The control group increased from week two to week six before decreasing at week 
eight. The treatment group increased from week two to week four. The plasma testosterone 
levels then decreased during week six and increased at week eight. At week two the control 
group plasma testosterone levels were higher at 0.6 ng/mL compared to the treatment group at 
0.3 ng/mL. At week four the control group plasma testosterone levels were lower at 0.7 ng/mL 
compared to the treatment group at 1.1 ng/mL. At week six the control group plasma testosterone 
levels were higher at 0.9 ng/mL compared to the treatment group at 0.4 ng/mL. At week eight the 
control group plasma testosterone levels were lower at 0.4 ng/mL compared to the treatment 
group at 0.5 ng/mL. 
Epididymal Sperm Density 
Epididymal sperm densities were not significantly different (Figure 32). There was a 
trending increase in both groups over the duration of the experiment concurrently. During week 
two the control group had a slightly lower sperm density of 8.2 million sperm/mg Cauda while 





control group had a slightly lower sperm density of 12.4 million sperm/mg Cauda while the 
treatment group had a sperm density of 12.7 million sperm/mg Cauda. During week six the 
control group had a slightly increased sperm density of 20.2 million sperm/mg Cauda while the 
treatment group had a sperm density of 19.4 million sperm/mg Cauda. During week eight the 
control group had an increased sperm density of 32.9 million sperm/mg Cauda while the 
















Figure 10.  Body weights of Sprague-Dawley rats measured every other day after receiving rat 
chow with 0% LS seed inclusion (Control; green diamond) and 15% LS seed inclusion 



































Figure 11.  Feed intake of Sprague-Dawley rats measured every day after receiving rat chow 































Figure 12.  Paired testicular weight (g/100 g BW) measured at each biological time point after 
receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion 














































Figure 13.  Paired epididymides weight (g/100 g BW) measured at each biological time point 
after receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed 












































Figure 14.  Prostate gland weight (g/100 g BW) measured at each biological time point after 
receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion 
(Treatment; orange diagonal stripes). * indicates significantly different at p<0.05 compared to 












































Figure 15.  Seminal vesicles weight (g/100 g BW) measured at each biological time point after 
receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion 













































Figure 16.  Kidney weights (g/100 g BW) measured at each biological time point after receiving 
rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion 
(Treatment; orange diagonal stripes). * indicates significantly different at p<0.05 compared to 











































Figure 17.  Adrenal gland weights (g/100 g BW) measured at each biological time point after 
receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion 









































Figure 18.  Heart weights (g/100 g BW) measured at each biological time point after receiving 
rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion 











































Figure 19.  Liver weights (g/100 g BW) measured at each biological time point after receiving 
rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion 





































Figure 20.  Spleen weights (g/100 g BW) measured at each biological time point after receiving 
rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion 






































Figure 21.  Paired lung weights (g/100 g BW) measured at each biological time point after 
receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion 












































Figure 22.  Brain weights (g/100 g BW) measured at each biological time point after receiving 
rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion 
(Treatment; orange diagonal stripes). * indicates significantly different at p<0.05 compared to 









































Figure 23.  Pancreatic weights (g/100 g BW) measured at each biological time point after 
receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion 
(Treatment; orange diagonal stripes). * indicates significantly different at p<0.05 compared to 




































Table 2. Effect of dietary supplementation of LS seeds on relative Bowman’s capsule diameter, glomerular diameter and 
difference in Bowman’s capsule and glomerulus diameter 
       
 
Bowman's Capsule Diameter (mm) Glomerulus Diameter (mm) 
Δ Bowman's Capsule and Glomerulus 
(mm) 
Week Control Treatment Control Treatment Control Treatment 
2 0.159 ± 0.0003 0.154 ± 0.0003 0.138 ± 0.0002 0.131 ± 0.0002 0.0210 ± 0.0001 0.0225 ± 0.0001 
4 0.182 ± 0.0002 0.174 ± 0.0002 0.158 ± 0.0002 0.147 ± 0.0002 * 0.0238 ± 0.0001 0.0264 ± 0.0001 
6 0.182 ± 0.0002 0.177 ± 0.0002 0.156 ± 0.0002 0.149 ± 0.0002   0.0260 ± 0.0001 0.0285 ± 0.0001 
8 0.164 ± 0.0003 0.186 ± 0.0002 * 0.145 ± 0.0002 0.155 ± 0.0002 * 0.0194 ± 0.0001 0.0311 ± 0.0001 * 















Table 3. Effect of dietary supplementation of LS seeds on disease presence of glomerulosclerosis, metaplasia and 
hyperplasia 
       
 
Glomerulosclerosis Presence (%) Metaplasia Presence (%) Hyperplasia Presence (%) 
Week Control Treatment Control Treatment Control Treatment 
2 27.62 ± 0.428 49.17 ± 0.418 * 29.52 ± 0.437 53.33 ± 0.417 * 44.76 ± 0.476 61.67 ± 0.407 
4 43.33 ± 0.415 69.17 ± 0.386 * 38.33 ± 0.407 86.67 ± 0.284 * 46.67 ± 0.417 85.00 ± 0.299 * 
6 39.13 ± 0.426 66.67 ± 0.394 * 25.22 ± 0.379 75.83 ± 0.358 * 46.96 ± 0.436 89.17 ± 0.260 * 
8 28.33 ± 0.377 75.00 ± 0.362 * 38.33 ± 0.407 82.50 ± 0.318 * 20.83 ± 0.340 81.67 ± 0.324 * 






Figure 24. Renal Bowman’s capsule and glomerulus from rats receiving A. 0% LS seed 
inclusion week 2 B. 15% LS seed inclusion week 2 C. 0% LS seed inclusion week 4 D. 15% LS 










Figure 25. Renal Bowman’s capsule and glomerulus from rats receiving A. 0% LS seed 
inclusion week 6 B. 15% LS seed inclusion week 6 C. 0% LS seed inclusion week 8 D. 15% LS 


















Table 4. Effect of dietary supplementation of LS seeds on proximal tubule diameter, proximal tubule degeneration, distal tubule 
diameter and distal tubule degeneration 
 
Proximal Tubule Diameter (mm) 
Proximal Tubule Degeneration Presence 
(%) 
Distal Tubule Diameter (mm) 
Distal Tubule Degeneration 
Presence (%) 
Week Control Treatment Control Treatment Control Treatment Control Treatment 
2 0.0496 ± 0.000218 0.0441 ± 0.000233 0.00 ± 0.000 35.00 ± 1.21 * 0.0458 ± 0.000193 0.0403 ± 0.000284 10.00 ± 0.760 77.50 ± 1.06 * 
4 0.0561 ± 0.000249 0.0559 ± 0.000212 2.50 ± 0.395 60.00 ± 1.24 * 0.0464 ± 0.000267 0.0451 ± 0.000241 20.00 ± 1.01 70.00 ± 1.16 * 
6 0.0542 ± 0.000261 0.0509 ± 0.000227 2.50 ± 0.395 47.50 ± 1.26 * 0.0476 ± 0.000287 0.0414 ± 0.000171 10.00 ± 0.760 85.00 ± 0.904 * 
8 0.0482 ± 0.000305 0.0561 ± 0.000227 * 0.00 ± 0.000 62.50 ± 1.23 * 0.0396 ± 0.000211 0.0507 ± 0.000309 * 15.00 ± 0.904 87.50 ± 0.837 * 





Figure 26. Renal proximal tubules rats receiving A. 0% LS seed inclusion week 2 B. 15% LS 
seed inclusion week 2 C. 0% LS seed inclusion week 4 D. 15% LS seed inclusion week 4. H&E 













Figure 27. Renal proximal tubules rats receiving A. 0% LS seed inclusion week 6 B. 15% LS 











Figure 28. Renal distal tubules rats receiving A. 0% LS seed inclusion week 2 B. 15% LS seed 













Figure 29. Renal distal tubules rats receiving A. 0% LS seed inclusion week 6 B. 15% LS seed 












Table 5. Effect of dietary supplementation of LS seeds on seminiferous tubule diameter, germinal cell 
layer thickness and Leydig cell diameter 
 
Seminiferous Tubules (mm) Germinal Cell Layer Thickness (mm) Leydig Cell Diameter (mm) 
Week Control Treatment Control Treatment Control Treatment 
2 0.300 ± 0.0004 0.306 ± 0.0004 0.0573 ± 0.0001 0.0548 ± 0.0001 0.0123 ± 0.00001 0.0134 ± 0.00001 *  
4 0.362 ± 0.0003 0.363 ± 0.0003 0.0638 ± 0.0001 0.0596 ± 0.0001 0.0139 ± 0.00001 0.0139 ± 0.00001   
6 0.343 ± 0.0003 0.355 ± 0.0003 0.0629 ± 0.0001 0.0600 ± 0.0001 0.0126 ± 0.00001 0.0130 ± 0.00001   
8 0.322 ± 0.0004 0.329 ± 0.0003 0.0562 ± 0.0001 0.0581 ± 0.0001 0.0125 ± 0.00001 0.0124 ± 0.00001   







Figure 30.  Perifusion of testis parenchyma from male Sprague-Dawley rats for testosterone. 
Control groups perifused with 0.01 M PBS (red square) and 0.01 M PBS + hCG (green triangle) 
while treatment groups were perifused with 0.01 M PBS (purple x) and 0.01 M PBS + hCG (blue 





















Control: 0.01 M PBS Control: 0.01M PBS + hCG

























































Figure 31.  Plasma testosterone from male Sprague-Dawley rats measured at each biological 
time point after receiving rat chow at 0% LS seed inclusion (Control; green diamond) and 15% 









































Figure 32.  Sperm density from male Sprague-Dawley rats measured at each biological time 
point after receiving rat chow at 0% LS seed inclusion (Control; green diamond) and 15% LS 













































Chapter VI: Discussion 
Our overall goals in these studies were first to determine the effect of LS seed 
consumption, both in the acute and chronic states, on the endocrinology of ovulation, secondly 
on the development of visceral organs and finally on the indices of spermatogenesis in the male 
rat model. We have demonstrated that a preovulatory surge-like GnRH secretion is inducible in 
vitro in the ovariectomized, estrogen-primed, progesterone treated rats. Our results indicated that 
LS supplementation tended to cause an earlier, attenuated preovulatory surge-like GnRH 
secretion.  
Temporally, LH secretion from the pituitary gland in all treatment groups decreased over 
time. Perifusate LH levels were high varying from 15 to 36 ng/mL pre-GnRH administration. We 
observed no stimulatory effect of 10 ng/mL GnRH administration. Consequently, no surge-like 
LH secretion was observed. Future studies should investigate the use of a higher concentration of 
GnRH to stimulate the surge of LH. There was however a suppressive effect of progesterone in 
progesterone treated rats on average LH secretion. 
Overall, FSH decreased from time 0 to about 180 minutes before stabilizing. Average 
FSH levels were significantly higher in ovariectomized, estrogen-primed, progesterone-treated 
rats compared to ovariectomized, estrogen-primed rats. LSE administration significantly 
increased average FSH secretion in ovariectomized, estrogen-primed rats but had no effect in the 
ovariectomized, estrogen-primed, progesterone-treated rats. Administration of GnRH at 10 
ng/mL had no effect of FSH secretion. Future studies should investigate the use of a higher 





FSH secretion because of the increased average FSH secretion observed in the ovariectomized, 
estrogen-primed, LSE treated rats. 
The observed earlier and attenuated surge-like secretion of GnRH is in line with Sharief 
et al. (2004) who observed LS seeds to have contraceptive properties in 100% of mice treated 
with one g/day administration of LS seeds orally. LS seeds utilized as an aqueous extract have 
also been shown to act as an abortifacient with unknown mechanisms (Nath, et al., 1992). 
Interestingly, 200 mg/Kg of ethanolic extract of LS seeds showed 0% inhibition of ovulation in 
copper acetate-induced ovulation (Vohora, et al., 1973). LS seeds have been shown to contain 
3.7 mg/g dry weight of lepidine with the highest content of lepidine in the plantlets at 10.4 mg/g 
during the vegetative state (Pande, et al., 2002). Lepidine could be a possible alkaloid that lends 
anti-ovulatory properties (Kumar & Sachin, 2013). To date, there have been no systematic 
studies completed on the effects of lepidine on reproductive function. Further research is needed 
to investigate if a higher concentration of LS seed aqueous extract is needed to yield anti-
ovulatory effects. Interestingly, female mice that were cyclooxygenase 2 (COX-2) deficient 
appeared to be infertile (Dinchuk, et al., 1995). LS seeds have been shown to have anti-
inflammatory properties (Raval, et al., 2009). Subsequently, LS seeds could have another 
pathway yielding anti-ovulatory properties by inhibiting COX-2. The anti-inflammatory 
mechanism for COX-1 or COX-2 inhibition specificity has not yet been elucidated for LS seeds. 
Our results indicate that there was a strong feed aversion for rats being fed 15% LS seed 
inclusion. This yielded a sharp decline in body weight for the LS-supplemented rats. The 
aversion lessened after the rats became convinced the LS supplemented feed was safe as evident 





similar between control and LS included groups. Weight changes increased over time 
concurrently between the two groups. These results were similar in broilers fed up to forty-two 
days at 0, 0.75, 1.50 and 2.25% LS seed inclusion (Shawle, et al., 2016). 
There was no effect of LS seed inclusion on adrenal gland, heart, liver, spleen or lungs. 
This is in agreement with previous results obtained in Wistar rats fed 10% LS seed inclusion 
(Datta et al., 2011).   Similarly, LS supplementation at 2.25 % of broilers had no effect on heart 
and liver weights (Shawle et al., 2016). We observed however a significant increase in brain 
weight in rats fed 15% LS seed inclusion during weeks four, six and eight. It is unknown why the 
brain weight increased. We speculate this may be due to water accretion in the brain. The exact 
mechanism by which this might have occurred is not clear. Future research is needed to delineate 
the molecular mechanisms surrounding the increased cerebral weight. There also was a 
significant increase in pancreatic weight during week eight. We speculate this was due to 
pancreatitis. Eddouks and Maghrani (2008) determined LS seeds to have hypoglycemic activity 
with no plasma insulin changes while collecting blood samples during a four-hour period of  
aqueous LS extract infusion. The authors attributed the hypoglycemic effects of LS seeds to be 
extra-pancreatic occurring possibly by inhibiting renal glucose reabsorption. The hypoglycemic 
state possibly caused a decreased release of pancreatic insulin secretion and therefore an increase 
in pancreatic weight. Further research is needed to investigate the effects of chronic consumption 
of LS seeds on pancreatic function. 
In our hands, chronic LS feeding had no significant effect on paired testicular, 
epididymides or seminal vesicle weight. However, the prostate gland showed a significant 





weeks four and eight for the treatment group. It is of interest to note that these are testosterone 
dependent organs displaying opposite weight changes. It is unclear why these differential weight 
changes have occurred.  
Histologically, there were no significant effect of LS supplementation on seminiferous 
tubule diameters or germinal cell layer thickness. There was however, an effect of acute but not 
chronic LS feeding on Leydig cell diameter. No significant Leydig cell diameter differences was 
observed in week four, six and eight. In vitro testosterone production did not differ significantly. 
There were also no significant changes in plasma testosterone. Therefore, our results provide no 
support for the aphrodisiac claims of LS seed ingestion (Mali, et al., 2007) at 15% inclusion. 
Future research should investigate the effect of different LS seed extracts on testosterone 
production and plasma levels. The increase in fertility for males may be a testosterone-
independent function.  
Chronic LS supplementation had neither stimulatory nor inhibitory effect on epididymal 
sperm density. This is different from results obtained by Naji et al. (2013a, 2013b) that 
investigated the effects of phenol and tocopherol extracts of LS seeds in male white rabbits. The 
authors determined the extracts to increase sperm concentration in the cauda epididymis and 
testis. The authors proposed the increased in sperm concentration was from the isothiocyanate or 
phenolic compounds with antioxidant activity similar to results from Gonzales et al. (2006) using 
Lepidium meyenii roots. The reason our results differed may be because Naji et al. (2013a, 
2013b) utilized phenol and tocopherol extractions that would yield a more concentrated extract 
of isothiocyante and phenolic compounds than our 15% inclusion of ground LS seeds. Christie 





antioxidant. The extraordinary effects of antioxidants like vitamin E have been shown to protect 
rabbit testes against lipid peroxidation and testosterone-induced lipid peroxidation (Aydilek, 
Aksakal, & Karakilҫik, 2004). Vitamin supplementation in boars increased semen production 
and percentage of motile sperm cells but did not affect sperm morphology or libido (Audet, 
Laforest, Martineau, & Matte, 2004). This yields evidence that the antioxidants within LS seeds 
can increase fertility in higher concentrations via different extracts. 
Both acute and chronic LS feeding significantly increased kidney weight in our study. 
Adam (1999) observed no renal abnormalities in Wistar rats fed 2% LS seed inclusion but at 
50% LS seed inclusion there were significant deleterious effects on the kidneys. The deleterious 
effects were less marked in rats fed 10% LS seed inclusion. In addition to the renal weight 
increase, histological analysis showed the LS supplementation induced significant increase in 
glomerulosclerosis and tubular degeneration throughout the duration of the study. Similar results 
were observed in Wistar rats fed 50% LS seed inclusion (Adam, 1999). At 2.25% LS seed 
inclusion in broilers, there was no kidney weight change (Shawle, et al., 2016). 
Glomerulosclerosis presents with sclerosis of the glomerulus and an increase in matrix 
(Sugahara, Hosaka, Mineshige, Kamiie, & Shirota, 2015). The increased matrix led to 
significantly-expanded Bowman’s space. Ingestion of LS seeds is a concern because nearly 20% 
of glomerular diseases are from glomerulosclerosis and glomerulosclerosis is a major cause of 
end-stage renal disease (Chen, et al., 2016). This therefore suggests that, in our hands, LS 






The weight increase can also be explained by significant presence of increased 
glomerular hyperplasia and metaplasia of the Bowman’s capsule. There was also significant 
increase in proximal and distal convoluted tubule diameter with significant tubular degeneration. 
Similar tubular degeneration was seen in Wistar rat’s that were fed 50% LS seeds and less 
marked in rats fed 10% LS seeds for three and six weeks and absent in rats fed 2% LS seeds 
(Adam, 1999).  
Interestingly, one study showed that ethanolic LS seed extract administration ameliorated 
renal tubular dilation (Yadav & Srivastava, 2012) caused by the anticancer drug cisplatin 
(Molitoris, Dahl, & Geerdes, 1992). Yadav et al. (2012) hypothesized the cisplatin induced 
oxidative stress nephrotoxicity was decreased by the antioxidant properties of the ethanolic 
extract of LS seeds. 
Transforming growth factor-β1 (TGF-β1) is a cytokine involved with glomerular 
extracellular matrix production in streptozotocin-induced diabetic rats (Schaan, et al., 2001). 
TGF-β1 is responsible for the generation of glomerulosclerosis in diabetic rats (Bertoluci, 
Schmid, Coimbra, & Lachat, 1996). In adult male Wistar rats, Eddouks et al. (2008) induced 
diabetes via streptozotocin injection and lowered plasma glucose levels concurrent with 
increased urinary glucose excretion over the course of fifteen days by administration of aqueous 
LS seed extract. The author’s hypothesized the aqueous LS seed extract inhibits renal glucose 
reabsorption. The diabetic rats treated with aqueous LS seed extract had similar urinary TGF-β1 
levels to diabetic control rats. Both diabetic rat TGF-β1 levels did decrease after fifteen days. 





seed extract may be masking the toxic effects of LS. In our study, there was a significant 
presence of glomerulosclerosis and renal tubular degeneration after fourteen days.  
Glomerulosclerosis and tubular atrophy are clinical manifestations of immunoglobulin A 
nephropathy (IgAN) (Mizerska-Wasiak, et al., 2014). N-acetylgalactosamine exposure is crucial 
to the pathogenesis of IgAN. Increased exposure to N-acetylgalactosamine is correlated with an 
increased risk factor for glomerulosclerosis (Xu, et al., 2014). N-acetylgalactosamine is located 
bound to the IgA1 hinge region on immunoglobulin A (Kerr, 1990). IgAN is characterized by the 
deposition of polymeric IgA1 within the renal mesangial cells (Donadio & Grande, 1997). Allen 
et al. (2001) and Hiki et al. (2001) demonstrated IgA1 molecules that had an aberrant O-
glycosylation deposited within the renal mesangial cells. With this evidence LS seed ingestion 
could result in the aforementioned renal toxicity by a(n) unknown phytochemical(s) in LS seeds 
by cleaving N-acetylgalactosamine from IgA1. Future research is needed to investigate the 











Chapter VII: Conclusion 
Aqueous LS seed extract had no significant effect on GnRH, LH or FSH secretions 
during preovulatory hormonal surge secretion. Aqueous LS seed supplementation demonstrated 
a tendency to advance and attenuate a preovulatory GnRH surge. Although limited studies have 
suggested an anti-ovulatory effect of LS seed ingestion, further research is needed to confirm 
this. Further, whereas chronic LS seed supplementation lead to no deleterious effects on testes, 
epididymides, seminal vesicles, adrenal glands, heart, liver, spleen and lungs, gross 
histopathology was observed in the kidney indicating nephrotoxicity. Deleterious effects in the 
weight of the prostate gland, brain and pancreas were also observed by chronic consumption of 
LS seeds. Overall, these results indicate a cautionary approach to the consumption of LS seeds 
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